, Tracking Stock Market Picks
Enter Symbol:
Glaxosmithkline Plc (GSK) [hlAlert]

down 23.10 %

Glaxosmithkline Plc (GSK) rated Buy by Deutsche Bank

Posted on: Tuesday,  May 28, 2013  8:25 AM ET by Deutsche Bank

Deutsche Bank rated Buy Glaxosmithkline Plc (NYSE: GSK) on 05/28/2013, when the stock price was $53.59. Since
then, Glaxosmithkline Plc has lost 23.10% as of 12/07/2015's recent price of $41.21.
If you would have followed this Deutsche Bank's recommendation on GSK, you would have lost 23.1% of your investment in 923 days.

GlaxoSmithKline plc (GSK) is a global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK?s principal pharmaceutical products include medicines in the therapeutic areas, such as respiratory, central nervous system, anti-virals, anti-bacterials, metabolic, vaccines, cardiovascular and urogenital, oncology and emesis. It has operations in some 114 countries and products sold in over 150 countries. The Company operates in two segments: Pharmaceuticals (prescription pharmaceuticals and vaccines) and Consumer Healthcare. On October 14, 2008, it acquired the Egyptian mature products business of Bristol Myers Squibb Company (BMS). In July 2009, BMS' branded generics business, which comprises a portfolio of 13 branded pharmaceuticals was acquired by the Company. In July 2009, GSK acquired Stiefel Laboratories, Inc.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/28/2013 8:25 AM Buy
as of 12/13/2013
1 Week down  -2.43 %
1 Month down  -1.09 %
3 Months down  -0.07 %
1 YTD down  -4.14 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy